Clinical trial
Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy
NCT01293903
Study timeline
Study start (unknown)2012-01-01Date precision: month
Registry last updated2017-08-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Dilated Cardiomyopathyunresolved
Heart Failureunresolved
Interventions
PlaceboDRUG
Sponsors & collaborators
Huazhong University of Science and Technologylead sponsor
Fudan Universitycollaborator
Shandong Provincial Hospitalcollaborator
RenJi Hospitalcollaborator
Tongji Hospitalcollaborator
Wuhan Universitycollaborator
Henan Provincial People's Hospitalcollaborator
Jining Medical Universitycollaborator
Second Hospital of Shanxi Medical Universitycollaborator
Shanxi Cardiovascular Hospitalcollaborator
Wuhan Pu-Ai Hospitalcollaborator
Yunyang Medical Collegecollaborator
China Three Gorges University, Yichang, Chinacollaborator
Xiangyang Central Hospitalcollaborator
Wuhan No.1 Hospitalcollaborator
Jingzhou Central Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01293903 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.